TY  - GEN
AU  - Cao,Su-Mei
AU  - Yang,Qi
AU  - Guo,Ling
AU  - Mai,Hai-Qiang
AU  - Mo,Hao-Yuan
AU  - Cao,Ka-Jia
AU  - Qian,Chao-Nan
AU  - Zhao,Chong
AU  - Xiang,Yan-Qun
AU  - Zhang,Xiu-Ping
AU  - Lin,Zhi-Xiong
AU  - Li,Wei-Xiong
AU  - Liu,Qing
AU  - Qiu,Fang
AU  - Sun,Rui
AU  - Chen,Qiu-Yan
AU  - Huang,Pei-Yu
AU  - Luo,Dong-Hua
AU  - Hua,Yi-Jun
AU  - Wu,Yi-Shan
AU  - Lv,Xing
AU  - Wang,Lin
AU  - Xia,Wei-Xiong
AU  - Tang,Lin-Quan
AU  - Ye,Yan-Fang
AU  - Chen,Ming-Yuan
AU  - Guo,Xiang
AU  - Hong,Ming-Huang
TI  - Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
SN  - 1879-0852
PY  - 2017///0807
KW  - Adolescent
KW  - Adult
KW  - Aftercare
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma
KW  - therapy
KW  - Chemoradiotherapy
KW  - adverse effects
KW  - Chemotherapy, Adjuvant
KW  - methods
KW  - Cisplatin
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Feasibility Studies
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Infusions, Intravenous
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Nasopharyngeal Carcinoma
KW  - Nasopharyngeal Neoplasms
KW  - Neoplasm Metastasis
KW  - Neutropenia
KW  - chemically induced
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.ejca.2016.12.039
ER  -